The biomarker, the protein kinase LRRK2, is a promising candidate for future exploration.
Several UAB programs ranked among the nation’s top 20 in 2017 edition of U.S. News & World Report’s “Best Graduate Schools."
The Birmingham Business Journal’s award recognizes UAB’s next generation of leaders for their efforts in health care policy and strategic planning.
UAB’s Community Engagement Institute brings academic researchers and community leaders together to brainstorm ways to improve Birmingham, the region and the world.
UAB is leading a team of researchers in a trial to combat blood pressure risk factors.
An interdisciplinary effort among the College of Arts and Sciences and several schools across campus results in a $2.5 million grant.
A series of fascinating studies at Harvard University showed that many people respond positively to placebo pills — even when they are told that the pills don't have any active ingredients. Now researchers at UAB have partnered with a Harvard scientist to test these "open-label" placebos for the first time in cancer survivors.
This improvement in cognition persists despite a high-glycemic-index diet, a possible risk factor for Alzheimer’s.
Four projects were awarded through the first School of Medicine AMC21 Reload Multi-Investigator Grants, a broad funding opportunity provided through the Academic Enrichment Fund that enables faculty members to organize and integrate multi-disciplinary teams of accomplished investigators to compete successfully for long-term extramural support.